메뉴 건너뛰기




Volumn 15, Issue 6, 2014, Pages 681-687

Effects of pitolisant, a histamine H3 inverse agonist, in drug-resistant idiopathic and symptomatic hypersomnia: A chart review

Author keywords

BF2.649; H3 receptor antagonist; Histamine; Idiopathic hypersomnia; Pitolisant; Sleepiness

Indexed keywords

ANTIDEPRESSANT AGENT; DEXAMPHETAMINE; MAZINDOL; METHYLPHENIDATE; MODAFINIL; OXYBATE SODIUM; PITOLISANT; 1-(3-(3-(4-CHLOROPHENYL)PROPOXY)PROPYL)PIPERIDINE; HISTAMINE AGONIST; PIPERIDINE DERIVATIVE;

EID: 84901633793     PISSN: 13899457     EISSN: 18785506     Source Type: Journal    
DOI: 10.1016/j.sleep.2014.01.021     Document Type: Article
Times cited : (68)

References (24)
  • 1
    • 20344399217 scopus 로고    scopus 로고
    • American Academy of Sleep Medicine, Chicago, IL, P. Hauri (Ed.), American Academy of Sleep Medicine
    • American Academy of Sleep Medicine The international classification of sleep disorders - revised 2005, American Academy of Sleep Medicine, Chicago, IL. P. Hauri (Ed.).
    • (2005) The international classification of sleep disorders - revised
  • 2
    • 67049119032 scopus 로고    scopus 로고
    • Idiopathic hypersomnia with and without long sleep time: a controlled series of 75 patients
    • Vernet C., Arnulf I. Idiopathic hypersomnia with and without long sleep time: a controlled series of 75 patients. Sleep 2009, 32:752-759.
    • (2009) Sleep , vol.32 , pp. 752-759
    • Vernet, C.1    Arnulf, I.2
  • 3
    • 77958617039 scopus 로고    scopus 로고
    • Subjective symptoms in idiopathic hypersomnia: beyond excessive sleepiness
    • Vernet C., Leu-Semenescu S., Buzare M., et al. Subjective symptoms in idiopathic hypersomnia: beyond excessive sleepiness. J Sleep Res 2010, 19:525-534.
    • (2010) J Sleep Res , vol.19 , pp. 525-534
    • Vernet, C.1    Leu-Semenescu, S.2    Buzare, M.3
  • 5
    • 62549089695 scopus 로고    scopus 로고
    • CSF histamine contents in narcolepsy, idiopathic hypersomnia and obstructive sleep apnea syndrome
    • Kanbayashi T., Kodama T., Kondo H., et al. CSF histamine contents in narcolepsy, idiopathic hypersomnia and obstructive sleep apnea syndrome. Sleep 2009, 32:181-187.
    • (2009) Sleep , vol.32 , pp. 181-187
    • Kanbayashi, T.1    Kodama, T.2    Kondo, H.3
  • 6
    • 77958579815 scopus 로고    scopus 로고
    • Cerebrospinal fluid histamine levels are decreased in patients with narcolepsy and excessive daytime sleepiness of other origin
    • Bassetti C.L., Baumann C.R., Dauvilliers Y., et al. Cerebrospinal fluid histamine levels are decreased in patients with narcolepsy and excessive daytime sleepiness of other origin. J Sleep Res 2010, 19:620-623.
    • (2010) J Sleep Res , vol.19 , pp. 620-623
    • Bassetti, C.L.1    Baumann, C.R.2    Dauvilliers, Y.3
  • 7
    • 84867045078 scopus 로고    scopus 로고
    • Normal cerebrospinal fluid histamine and tele-methylhistamine levels in hypersomnia conditions
    • Dauvilliers Y., Delallee N., Jaussent I., et al. Normal cerebrospinal fluid histamine and tele-methylhistamine levels in hypersomnia conditions. Sleep 2012, 35:1359-1366.
    • (2012) Sleep , vol.35 , pp. 1359-1366
    • Dauvilliers, Y.1    Delallee, N.2    Jaussent, I.3
  • 8
    • 36849065939 scopus 로고    scopus 로고
    • Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin
    • Morgenthaler T., Kapur V., Brown T., et al. Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin. Sleep 2007, 30:1705-1711.
    • (2007) Sleep , vol.30 , pp. 1705-1711
    • Morgenthaler, T.1    Kapur, V.2    Brown, T.3
  • 9
    • 79957997424 scopus 로고    scopus 로고
    • Benefit and risk of modafinil in idiopathic hypersomnia versus. narcolepsy with cataplexy
    • Lavault S., Dauvilliers Y., Drouot X., et al. Benefit and risk of modafinil in idiopathic hypersomnia versus. narcolepsy with cataplexy. Sleep Med 2011, 12:550-556.
    • (2011) Sleep Med , vol.12 , pp. 550-556
    • Lavault, S.1    Dauvilliers, Y.2    Drouot, X.3
  • 10
    • 75749085837 scopus 로고    scopus 로고
    • Idiopathic hypersomnia: clinical features and response to treatment
    • Ali M., Auger R., Slocumb N., et al. Idiopathic hypersomnia: clinical features and response to treatment. J Clin Sleep Med 2009, 5:562-568.
    • (2009) J Clin Sleep Med , vol.5 , pp. 562-568
    • Ali, M.1    Auger, R.2    Slocumb, N.3
  • 11
    • 35148900346 scopus 로고    scopus 로고
    • Idiopathic hypersomnia: a study of 77 cases
    • Anderson K., Pilsworth S., Sharples L., et al. Idiopathic hypersomnia: a study of 77 cases. Sleep 2007, 30:1274-1281.
    • (2007) Sleep , vol.30 , pp. 1274-1281
    • Anderson, K.1    Pilsworth, S.2    Sharples, L.3
  • 12
    • 84856490407 scopus 로고    scopus 로고
    • Quality of life in patients with narcolepsy with cataplexy, narcolepsy without cataplexy, and idiopathic hypersomnia without long sleep time: comparison between patients on psychostimulants, drug-naive patients and the general Japanese population
    • Ozaki A., Inoue Y., Hayashida K., et al. Quality of life in patients with narcolepsy with cataplexy, narcolepsy without cataplexy, and idiopathic hypersomnia without long sleep time: comparison between patients on psychostimulants, drug-naive patients and the general Japanese population. Sleep Med 2012, 13:200-206.
    • (2012) Sleep Med , vol.13 , pp. 200-206
    • Ozaki, A.1    Inoue, Y.2    Hayashida, K.3
  • 13
    • 84872339899 scopus 로고    scopus 로고
    • Mazindol in narcolepsy and idiopathic and symptomatic hypersomnia refractory to stimulants: a long-term chart review
    • Nittur N., Konofal E., Dauvilliers Y., et al. Mazindol in narcolepsy and idiopathic and symptomatic hypersomnia refractory to stimulants: a long-term chart review. Sleep Med 2013, 14:30-36.
    • (2013) Sleep Med , vol.14 , pp. 30-36
    • Nittur, N.1    Konofal, E.2    Dauvilliers, Y.3
  • 14
    • 40849137722 scopus 로고    scopus 로고
    • An inverse agonist of the histamine H(3) receptor improves wakefulness in narcolepsy: studies in orexin-/- mice and patients
    • Lin J.S., Dauvilliers Y., Arnulf I., et al. An inverse agonist of the histamine H(3) receptor improves wakefulness in narcolepsy: studies in orexin-/- mice and patients. Neurobiol Dis 2008, 30:74-83.
    • (2008) Neurobiol Dis , vol.30 , pp. 74-83
    • Lin, J.S.1    Dauvilliers, Y.2    Arnulf, I.3
  • 15
    • 84885378478 scopus 로고    scopus 로고
    • Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial
    • Dauvilliers Y., Bassetti C., Lammers G.J., et al. Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial. Lancet Neurol 2013, 12:1068-1075.
    • (2013) Lancet Neurol , vol.12 , pp. 1068-1075
    • Dauvilliers, Y.1    Bassetti, C.2    Lammers, G.J.3
  • 16
    • 84862791691 scopus 로고    scopus 로고
    • Pitolisant, an inverse agonist of the histamine H3 receptor: an alternative stimulant for narcolepsy-cataplexy in teenagers with refractory sleepiness
    • Inocente C., Arnulf I., Bastuji H., et al. Pitolisant, an inverse agonist of the histamine H3 receptor: an alternative stimulant for narcolepsy-cataplexy in teenagers with refractory sleepiness. Clin Neuropharmacol 2012, 35:55-60.
    • (2012) Clin Neuropharmacol , vol.35 , pp. 55-60
    • Inocente, C.1    Arnulf, I.2    Bastuji, H.3
  • 18
    • 79958026433 scopus 로고    scopus 로고
    • The histamine H3 receptor: from discovery to clinical trials with pitolisant
    • Schwartz J.C. The histamine H3 receptor: from discovery to clinical trials with pitolisant. Br J Pharmacol 2011, 163:713-721.
    • (2011) Br J Pharmacol , vol.163 , pp. 713-721
    • Schwartz, J.C.1
  • 19
    • 84883768395 scopus 로고    scopus 로고
    • Alerting and psychomotor performance effects of the histamine H3 inverse agonist MK-0249 in obstructive sleep apnea patients on CPAP with excessive daytime sleepiness: a randomized adaptive crossover study
    • Herring W., Liu K., Hutzelmann J., et al. Alerting and psychomotor performance effects of the histamine H3 inverse agonist MK-0249 in obstructive sleep apnea patients on CPAP with excessive daytime sleepiness: a randomized adaptive crossover study. Sleep Med 2013, 14:955-963.
    • (2013) Sleep Med , vol.14 , pp. 955-963
    • Herring, W.1    Liu, K.2    Hutzelmann, J.3
  • 20
    • 34548324621 scopus 로고    scopus 로고
    • Influence of (R)-alpha-methylhistamine on the histamine H3 receptor in the rat gastrointestinal tract
    • Chazot P., Shenton F., Schunack W., et al. Influence of (R)-alpha-methylhistamine on the histamine H3 receptor in the rat gastrointestinal tract. Inflamm Res 2007, 56(Suppl 1):S19-S20.
    • (2007) Inflamm Res , vol.56 , Issue.SUPPL. 1
    • Chazot, P.1    Shenton, F.2    Schunack, W.3
  • 21
    • 33645130900 scopus 로고    scopus 로고
    • Selective expression of histamine receptors H1R, H2R, and H4R, but not H3R, in the human intestinal tract
    • Sander L.E., Lorentz A., Sellge G., et al. Selective expression of histamine receptors H1R, H2R, and H4R, but not H3R, in the human intestinal tract. Gut 2006, 55:498-504.
    • (2006) Gut , vol.55 , pp. 498-504
    • Sander, L.E.1    Lorentz, A.2    Sellge, G.3
  • 23
    • 84856716148 scopus 로고    scopus 로고
    • Increasing histamine neurotransmission in Gilles de la Tourette syndrome
    • Hartmann A., Worbe Y., Arnulf I. Increasing histamine neurotransmission in Gilles de la Tourette syndrome. J Neurol 2011, 259:375-376.
    • (2011) J Neurol , vol.259 , pp. 375-376
    • Hartmann, A.1    Worbe, Y.2    Arnulf, I.3
  • 24
    • 84877837311 scopus 로고    scopus 로고
    • Preclinical evaluation of the abuse potential of pitolisant, a histamine H3 receptor inverse agonist/antagonist compared with modafinil
    • Uguen M., Perrin D., Belliard S., et al. Preclinical evaluation of the abuse potential of pitolisant, a histamine H3 receptor inverse agonist/antagonist compared with modafinil. Br J Pharmacol 2013, 169:632-644.
    • (2013) Br J Pharmacol , vol.169 , pp. 632-644
    • Uguen, M.1    Perrin, D.2    Belliard, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.